The CTR, one of three entities within the CHI Institute
for Research and next day delivery cialis
Innovation (CIRI), collaborates with biomedical researchers to focus on the intersection of biomedical advances in omics
-based diagnostics and generic viagra in canada
precision medicine. Under the terms of the signed lease, half of the CTR's overall anticipated 50-person work force will occupy more than 11,000 square feet of laboratory and buy viagra now
office space within the BioPark.
"It's exciting to add the CHI Center for Translational Research to our growing list of BioPark occupants," said Jim Hughes, President, Research Park Corporation, University of Maryland, Baltimore. "This organization is national in scope – and yet we are able to offer them an ideal location that allows the Center to stay local – moving from Baltimore County to the UM BioPark. Here, they have access to the University of Maryland School of Medicine and Medical Center, as well as the opportunity to be part of a growing life sciences community."
The CTR state-of-the-art research facility, coupled with its 80+hospital network, supports discovery, product development and where to get viagra cheap clinical implementation needs for biomedical researchers. The Center is advancing personalized medicine by translating scientific advances into real clinical solutions.
"While performing our due diligence as a national organization, we looked at locations throughout Maryland and in other parts of the country, including Northern and buy no rx cialis Southern California," said Jeffrey M. Otto, National Director, CTR. "The UM BioPark offered the best options for us in terms of amenities, location, design and viagra pharmacy facilities. We're pleased to be able to grow our organization and to offer critical services for biomedical researchers from our operational base in Baltimore."
About Catholic Health Initiatives
Catholic Health Initiatives is a national nonprofit health system with headquarters in Englewood, Colorado. The faith-based system operates in 18 states and includes 87 hospitals; 40 long-term care, assisted- and residential-living facilities; two academic medical centers; two community health-services organizations; two accredited nursing colleges; and home health agencies. CHI is the nation's third-largest faith-based health system, with annual operating revenues of more than $12 billion and approximately 85,500 employees. In fiscal year 2012, CHI provided more than $715 million in charity care and community benefit, including services for the poor, free clinics, education and research. To learn more about CHI, visit http://www.catholichealthinit.org/.
About CHI Institute for Research and Innovation
As one of the largest faith-based providers of community-based care in the era of health care reform, CHI recognizes the necessity of innovation to sustain and grow. The formation of CIRI signaled a clear commitment to the health care community and industry stakeholders that CHI is a vested participant in the process of innovation. It also highlighted the strategic prioritization of innovation at CHI, which has a long history of pioneering models and systems to enhance care delivery and patient access. In 2007, CHI recognized that health care innovation could be served and sustained through an independent research company, which could foster partnerships with private, government and corporate partners to support its mission. Staffed by fully dedicated research and innovation professionals, CIRI has a programmatic focus on three main areas the present challenges and opportunities to modern health care:
- Access to sustainable quality care to create healthy communities
- Access to, and participation in, research on the latest innovations in medicines and medical devices
- Advancing personalized medicine in community health care
To learn more about CIRI, visit http://www.chiresearch.org/.
About CHI Center for Translational Research
The Catholic Health Initiatives Center for Translational Research (CTR) partners with biomedical researchers to assist in the development of next-generation drugs, diagnostics and devices, thus enabling promise of precision medicine. The state-of-the-art research facility, coupled with the CHI 80+ hospital network, is here to support the discovery, product development and clinical implementation needs of academia, government and biopharma. Together with our partners, we advance personalized medicine by translating scientific advances into real clinical solutions. This is accomplished through leveraging the strength, power and reach of the 5th largest health system in the United States. To learn more about the CTR, visit http://www.chiresearch.org/CTR.
About the University of Maryland BioPark
The UM BioPark is a biomedical research park on the campus of the University of Maryland, Baltimore. The BioPark welcomes additional life science companies to join its growing scientific community of emerging, high-growth life science tenants and University of Maryland (UM) translational research and clinical treatment centers. For early-stage to mature bioscience companies, the BioPark offers a sophisticated laboratory and office environment on the UM's vibrant academic medical center campus. Community members are commercializing new drugs, diagnostics and devices and advancing biomedical research. Learn more about BioPark tenants at http://www.umbiopark.com/tenants.aspx.
SOURCE University of Maryland BioPark